We are live on ! Find out more
Fayez Sarofim & Co

Fayez Sarofim & Co Portfolio holdings

AUM $39.1B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
-0.73%
1 Year Est. Return
+15.14%
3 Year Est. Return
+57.14%
5 Year Est. Return
+86.44%
10 Year Est. Return
+281.86%
AUM
$21B
AUM Growth
-$562M
Cap. Flow
-$305M
Cap. Flow %
-1.45%
Top 10 Hldgs %
43.23%
Holding
256
New
8
Increased
47
Reduced
126
Closed
11

Top Buys

Rank Stock Value
1
UNP icon
Union Pacific
UNP
+$92M
2
GILD icon
Gilead Sciences
GILD
+$86.1M
3
CB icon
Chubb
CB
+$11.5M
4
EOG icon
EOG Resources
EOG
+$8.76M
5
STT icon
State Street
STT
+$7.72M

Top Sells

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$55.5M
2
AAPL icon
Apple
AAPL
+$32.3M
3
GE icon
GE Aerospace
GE
+$32.1M
4
XOM icon
ExxonMobil
XOM
+$31.5M
5
KMI icon
Kinder Morgan
KMI
+$22.7M

Sector Composition

Rank Sector Weight
1 Consumer Staples 27.96%
2 Energy 25.29%
3 Financials 12.53%
4 Healthcare 10.76%
5 Technology 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AOL
151
DELISTED
AOL INC COMMON STOCK
AOL
$887K ﹤0.01%
20,253
+13
+0.1% +$587
HWC icon
152
Hancock Whitney
HWC
$6.19B
$870K ﹤0.01%
23,743
+249
+1% +$8.85K
NKE icon
153
Nike
NKE
$64.1B
$866K ﹤0.01%
23,440
+1,912
+9% +$72.3K
CCEP icon
154
Coca-Cola Europacific Partners
CCEP
$49.1B
$860K ﹤0.01%
18,000
– –
EQIX icon
155
Equinix
EQIX
$99.4B
$811K ﹤0.01%
4,385
– –
ROK icon
156
Rockwell Automation
ROK
$51.1B
$772K ﹤0.01%
6,200
– –
NOV icon
157
NOV
NOV
$6.84B
$767K ﹤0.01%
10,917
-591
-5% -$40.5K
UN
158
DELISTED
Unilever NV New York Registry Shares
UN
$741K ﹤0.01%
18,032
+205
+1% +$7.97K
ISRG icon
159
Intuitive Surgical
ISRG
$127B
$726K ﹤0.01%
14,418
-1,179,072
-99% -$55.5M
WWE
160
DELISTED
World Wrestling Entertainment
WWE
$724K ﹤0.01%
25,070
– –
ITGR icon
161
Integer Holdings
ITGR
$3.39B
$719K ﹤0.01%
17,168
– –
MMP
162
DELISTED
Magellan Midstream Partners, L.P.
MMP
$717K ﹤0.01%
10,278
+5,000
+95% +$333K
SBUX icon
163
Starbucks
SBUX
$119B
$702K ﹤0.01%
19,132
+1,694
+10% +$62.7K
MA icon
164
Mastercard
MA
$498B
$698K ﹤0.01%
9,350
– –
AMGN icon
165
Amgen
AMGN
$209B
$676K ﹤0.01%
5,481
-125
-2% -$15.2K
APC
166
DELISTED
Anadarko Petroleum
APC
$673K ﹤0.01%
7,943
-8,838
-53% -$725K
RF icon
167
Regions Financial
RF
$26.4B
$648K ﹤0.01%
58,365
– –
CSX icon
168
CSX Corp
CSX
$94B
$637K ﹤0.01%
66,000
– –
ECOL
169
DELISTED
US Ecology, Inc.
ECOL
$607K ﹤0.01%
16,370
– –
DNB
170
DELISTED
Dun & Bradstreet
DNB
$591K ﹤0.01%
5,950
-50
-0.8% -$5.26K
BPL
171
DELISTED
Buckeye Partners, L.P.
BPL
$571K ﹤0.01%
7,610
– –
AET
172
DELISTED
Aetna Inc
AET
$560K ﹤0.01%
7,468
+53
+0.7% +$3.75K
DVA icon
173
DaVita
DVA
$15.5B
$558K ﹤0.01%
8,100
-200
-2% -$13.3K
COST icon
174
Costco
COST
$432B
$517K ﹤0.01%
4,625
-140
-3% -$16K
BEAM
175
DELISTED
BEAM INC COM STK (DE)
BEAM
$510K ﹤0.01%
6,120
-4,096
-40% -$333K
5 6
7
8 9

Similar funds

Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
Parallax Volatility Advisers
Parallax Volatility Advisers San Francisco, California $38.6B AUM 45.89% 1-Year Est. Return
Empower Advisory Group
Empower Advisory Group Greenwood Village, Colorado $38.5B AUM 18.4% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Credit Agricole
Credit Agricole Montrouge Cedex, France $38.1B AUM
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Fayez Sarofim & Co's Q1 2014 Portfolio in Review

As of Q1 2014, Fayez Sarofim & Co held 256 positions worth $21B, down 2.6% from $21.5B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Fayez Sarofim & Co's Q1 2014 filing shows 8 new, 47 increased, 126 reduced and 11 closed positions. Its largest new stake was Gilead Sciences: 1,098,306 shares worth $78.4M. The largest sale was Intuitive Surgical, an estimated $55.5M.

By sector, the portfolio is most concentrated in Consumer Staples at 28% of assets, down from 29% a quarter earlier, followed by Energy and Financials.

  • Fayez Sarofim & Co's largest Q1 2014 buy was Gilead Sciences: 1,098,306 shares worth $78.4M.
  • Fayez Sarofim & Co added most to Union Pacific in Q1 2014, an estimated $92M increase.
  • Fayez Sarofim & Co's biggest Q1 2014 reduction was Intuitive Surgical, cutting an estimated $55.5M.
  • Fayez Sarofim & Co fully exited State Street SPDR S&P 500 ETF Trust in Q1 2014, selling an estimated $3.03M.
  • Fayez Sarofim & Co's ten largest holdings make up 43% of its $21B portfolio in Q1 2014.
  • Fayez Sarofim & Co opened 8 new positions and closed 11 in Q1 2014.
  • Fayez Sarofim & Co's portfolio value fell 2.6% quarter-over-quarter to $21B.

Based on Fayez Sarofim & Co's 13F filing for Q1 2014, filed 14 May 2014.